Cargando…

Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease

Background: Sarcopenia is thought to be related to an increased risk of non-alcoholic steatohepatitis and advanced liver fibrosis. Our cross-sectional single-center study was designed to analyze the prevalence of sarcopenia in patients with NAFLD and possible influencing factors. Methods: A survey o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheptulina, Anna F., Yafarova, Adel A., Golubeva, Julia A., Mamutova, Elvira M., Kiselev, Anton R., Drapkina, Oxana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302668/ https://www.ncbi.nlm.nih.gov/pubmed/37373921 http://dx.doi.org/10.3390/jpm13060932

Ejemplares similares

Reduced Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease May Be Associated with Depression and Fatigue
por: Golubeva, Julia A., et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
por: Drapkina, Oxana M., et al.
Publicado: (2023)

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
por: Golubeva, Julia A., et al.
Publicado: (2023)

Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives
por: Drapkina, Oxana M., et al.
Publicado: (2022)

Possible Mechanisms Linking Obesity, Steroidogenesis, and Skeletal Muscle Dysfunction
por: Sheptulina, Anna F., et al.
Publicado: (2023)

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis Methods
por: Korobeinikova, Anna V., et al.
Publicado: (2023)

Epicardial fat as the predictor for essential hypertension and early vascular damage in patients with metabolic syndrome and non-alcoholic fatty liver disease
por: Drapkina, J., et al.
Publicado: (2014)

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
por: Iwaki, Michihiro, et al.
Publicado: (2023)

Association of Vital Exhaustion with Risk Factors for Cardiovascular Diseases, Quality of Life and Lifestyle in 41–44-Year-Old Muscovite Men
por: Kotova, Marina B., et al.
Publicado: (2021)

Analysis of Adverse Events in the Treatment of Patients with Non-Valvular Atrial Fibrillation with Oral Anticoagulants: Data from the “ANTEY” Observational Study
por: Martsevich, Sergey Yu., et al.
Publicado: (2022)

Diversities in the Gut Microbial Patterns in Patients with Atherosclerotic Cardiovascular Diseases and Certain Heart Failure Phenotypes
por: Drapkina, Oxana M., et al.
Publicado: (2022)

Diabetes related fatigue sarcopenia, frailty
por: Lien, Angela Shin‐Yu, et al.
Publicado: (2017)

Fatigue and primary sarcopenia in geriatric patients
por: Suzan, Veysel, et al.
Publicado: (2022)

Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
por: Tovo, Cristiane V, et al.
Publicado: (2017)

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
por: Golabi, Pegah, et al.
Publicado: (2020)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
por: Almeida, Naiade Silveira, et al.
Publicado: (2022)

Examining time–frequency mechanisms of full-fledged deep sleep development in newborns of different gestational age in the first days of their postnatal development
por: Kiselev, Anton R., et al.
Publicado: (2022)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults
por: Lee, Inhwan, et al.
Publicado: (2020)

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
por: Moon, Joon Ho, et al.
Publicado: (2021)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Atrial contractile function and fibrosis in patients with paroxysmal atrial fibrillation in sinus rhythm
por: Yaroslav, Ashikhmin, et al.
Publicado: (2022)

Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer
por: Nipp, Ryan D., et al.
Publicado: (2017)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
por: Yu, Rui, et al.
Publicado: (2018)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Effects of Managing Cancer and Living Meaningfully on Cancer-Related Fatigue and Cytokine Levels in Gastrointestinal Cancer Patients
por: Cai, Yinlian, et al.
Publicado: (2023)

The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder
por: Smith, Bradley H., et al.
Publicado: (2002)

Where's the Bar? Alcohol and Meaningful Engagement Among Assisted Living Residents With Dementia
por: Bender, Alexis, et al.
Publicado: (2021)

Good is not meaningful?
por: Zaidi, Shabih, et al.
Publicado: (2022)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
por: Turkoz, Ibrahim, et al.
Publicado: (2021)

Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: Gonzalez, Andrea, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
por: Cho, Yongin, et al.
Publicado: (2023)

Fatty acid amides as potential circulating biomarkers for sarcopenia
por: Kim, Ye An, et al.
Publicado: (2023)

Interaction between sarcopenia and nonalcoholic fatty liver disease
por: Joo, Sae Kyung, et al.
Publicado: (2023)

Transcriptome of Extracellular Vesicles: State-of-the-Art
por: Turchinovich, Andrey, et al.
Publicado: (2019)

Impact of National Tobacco Control Policy on Rates of Hospital Admission for Pneumonia: When Compliance Matters
por: Gambaryan, Marine, et al.
Publicado: (2023)

Crisis as the Catalyst for Meaningful Change
por: LaRochelle, Jeffrey S., et al.
Publicado: (2022)

Association of Fatigue With Sarcopenia and its Elements: A Secondary Analysis of SABE-Bogotá
por: Patino-Hernandez, Daniela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7da7k7hsf8cpr0n5jm1aal3hq8